Aptosis Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 01-01-2025
- Paid Up Capital ₹ 0.10 M
as on 01-01-2025
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
About Aptosis Lifesciences
The Corporate was formerly known as Therazen Lifescience Private Limited. The Company is engaged in the Household Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nandkishor Managoli, Umang Shah, Shailesh Shah, and Two other members serve as directors at the Company.
- CIN/LLPIN
U22100MP2012PTC029507
- Company No.
029507
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Nov 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aptosis Lifesciences?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umang Shah  | Director | 05-Nov-2012 | Current |
| Shailesh Shah | Director | 05-Nov-2012 | Current |
| Nandkishor Managoli | Director | 18-Apr-2018 | Current |
| Savita Managoli | Director | 18-Apr-2018 | Current |
| Minesh Patil | Additional Director | 18-Apr-2018 | Current |
Financial Performance of Aptosis Lifesciences.
Aptosis Lifesciences Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Aptosis Lifesciences?
In 2017, Aptosis Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Seven Lifesciences Private LimitedActive 13 years 7 monthsNandkishor Managoli and Savita Managoli are mutual person
- Mendel Academy Private LimitedActive 2 years 8 months
Nandkishor Managoli and Savita Managoli are mutual person
- Uss Bansuriwala Tradexim Private LimitedActive 12 years 5 months
Umang Shah and Shailesh Shah are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aptosis Lifesciences?
Unlock and access historical data on people associated with Aptosis Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aptosis Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aptosis Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
